|
End-of-day quote
2026-10-16
|
5-day change
|
1st Jan Change
|
|
0.000001 USD
|
0.00%
|
 |
0.00%
|
-
|
|
24-03-25 |
Infinity Pharmaceuticals, Inc. Went Out of Business
|
CI
| |
24-03-06 |
Revised Liquidation Plan Approved for Infinity Pharmaceuticals, Inc.
|
CI
| |
24-02-21 |
Motion for Di Minimis Assets Sale Approved for Infinity Pharmaceuticals, Inc.
|
CI
| |
24-02-14 |
An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).
|
CI
| |
24-02-12 |
First Motion for Exclusivity Period Extension Approved For Infinity Pharmaceuticals, Inc.
|
CI
| |
24-02-01 |
Disclosure Statement Approved on Interim Basis for Infinity Pharmaceuticals, Inc.
|
CI
| |
24-01-25 |
First Motion for Exclusivity Period Extension Filed by Infinity Pharmaceuticals, Inc.
|
CI
| |
24-01-10 |
Joint Liquidation Plan and Disclsoure Statement Filed by Infinity Pharmaceuticals, Inc.
|
CI
| |
24-01-07 |
Motion for Asset Sale Approved for Infinity Pharmaceuticals, Inc.
|
CI
| |
23-10-23 |
Bidding Procedure Approved for Infinity Pharmaceuticals, Inc.
|
CI
| |
23-10-02 |
Motion for Joint Administration Approved for Infinity Pharmaceuticals, Inc.
|
CI
| |
23-09-29 |
Infinity Pharmaceuticals : Bankruptcy - Form 8-K
|
PU
| |
23-09-29 |
Infinity Pharmaceuticals, Inc. Announces Resignation of Adelene Perkins from the Board
|
CI
| |
23-09-29 |
Motion for Asset Sale Filed by Infinity Pharmaceuticals, Inc.
|
CI
| |
23-09-29 |
Motion for Joint Administration Filed by Infinity Pharmaceuticals, Inc.
|
CI
| |
23-09-29 |
Infinity Pharmaceuticals, Inc. Filed for Bankruptcy
|
CI
| |
23-09-18 |
Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from S&P TMI Index
|
CI
| |
23-09-13 |
Infinity Pharmaceuticals, Inc.(OTCPK:INFI) dropped from NASDAQ Composite Index
|
CI
| |
23-09-01 |
Infinity Pharmaceuticals, Inc. Announces Resignation of Robert Ilaria, Jr., M.D., as Chief Medical Officer
|
CI
| |
23-09-01 |
Infinity Pharmaceuticals, Inc. Announces Chief Executive Officer Changes
|
CI
| |
23-08-18 |
INFINITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
|
BU
| |
23-08-10 |
Infinity Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
|
CI
| |
23-07-25 |
Infinity Pharmaceuticals, Inc. Announces Resignation of Samuel Agresta, Sujay R. Kango and Brian Schwartz from Board
|
CI
| |
23-07-25 |
Infinity Pharmaceuticals Announces Value Preservation and Maximization Plan
|
BU
| |
23-07-24 |
Infinity Pharmaceuticals Announces Termination of Merger Agreement with MEI Pharma
|
BU
|
Become a member to access more news New memberNo results match your criteria Select your edition All financial news and data tailored to specific country editions | 
